Cargando…

Clinical impact of inflammation in dry eye disease: proceedings of the ODISSEY group meeting

Dry eye disease (DED) is a common, multifactorial ocular condition with major impact on vision and quality of life. It is now well recognized that the pathophysiology of chronic DED can include a cycle of inflammation involving both innate and adaptive immune responses. Recently, in vitro/in vivo mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baudouin, Christophe, Irkeç, Murat, Messmer, Elisabeth M., Benítez‐del‐Castillo, José M., Bonini, Stefano, Figueiredo, Francisco C., Geerling, Gerd, Labetoulle, Marc, Lemp, Michael, Rolando, Maurizio, Van Setten, Gysbert, Aragona, Pasquale
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836968/ https://www.ncbi.nlm.nih.gov/pubmed/28390092 http://dx.doi.org/10.1111/aos.13436

Ejemplares similares

Diagnosing the severity of dry eye: a clear and practical algorithm
por: Baudouin, Christophe, et al.
Publicado: (2014)

Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction
por: Baudouin, Christophe, et al.
Publicado: (2016)

The Enduring Experience in Dry Eye Diagnosis: A Non-Interventional Study Comparing the Experiences of Patients Living With and Without Sjögren’s Syndrome
por: Figueiredo, Francisco C., et al.
Publicado: (2021)

Dry Eye Etiology: Focus on Friction
por: van Setten, Gysbert Botho, et al.
Publicado: (2020)

Impact of Attrition, Intercellular Shear in Dry Eye Disease: When Cells are Challenged and Neurons are Triggered
por: van Setten, Gysbert-Botho
Publicado: (2020)

Management of inflammation in dry eye disease: Recommendations from a European panel of experts
por: Messmer, Elisabeth M, et al.
Publicado: (2022)

Special Issue “Managing Dry Eye Disease over Time: An Italian Consensus Conference”
por: Aragona, Pasquale, et al.
Publicado: (2022)

Patient-reported burden and overall impact of dry eye disease across eight European countries: a cross-sectional web-based survey
por: Boboridis, Kostas G, et al.
Publicado: (2023)

Artificial Tears: Biological Role of Their Ingredients in the Management of Dry Eye Disease
por: Labetoulle, Marc, et al.
Publicado: (2022)

Dealing with the Persistent Pathogenic Issues of Dry Eye Disease: The Importance of External and Internal Stimuli and Tissue Responses
por: Rolando, Maurizio, et al.
Publicado: (2023)

The Effects of High Molecular Weight Hyaluronic Acid Eye Drop Application in Environmental Dry Eye Stress Model Mice
por: Kojima, Takashi, et al.
Publicado: (2020)

The Management of Dry Eye Disease: Proceedings of Italian Dry Eye Consensus Group Using the Delphi Method
por: Aragona, Pasquale, et al.
Publicado: (2022)

A Randomized Study of the Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in Treatment of Moderate to Severe Dry Eye
por: Baudouin, Christophe, et al.
Publicado: (2017)

Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies
por: Leonardi, Andrea, et al.
Publicado: (2019)

Osmoprotectants, carboxymethylcellulose and hyaluronic acid multi-ingredient eye drop: a randomised controlled trial in moderate to severe dry eye
por: Labetoulle, M, et al.
Publicado: (2017)

Osmoprotectants, carboxymethylcellulose and hyaluronic acid multi-ingredient eye drop: a randomised controlled trial in moderate to severe dry eye
por: Labetoulle, M, et al.
Publicado: (2017)

The HYLAN M Study: Efficacy of 0.15% High Molecular Weight Hyaluronan Fluid in the Treatment of Severe Dry Eye Disease in a Multicenter Randomized Trial
por: van Setten, Gysbert-Botho, et al.
Publicado: (2020)

Modern approach to the treatment of dry eye, a complex multifactorial disease: a P.I.C.A.S.S.O. board review
por: Aragona, Pasquale, et al.
Publicado: (2021)

Defining Dry Eye from a Clinical Perspective
por: Tsubota, Kazuo, et al.
Publicado: (2020)

Ocular Surface Allostasis—When Homeostasis Is Lost: Challenging Coping Potential, Stress Tolerance, and Resilience
por: van Setten, Gysbert-Botho
Publicado: (2023)

Iatrogenic Dry Eye Disease: Dealing with the Conundrum of Post-Cataract Discomfort. A P.I.C.A.S.S.O. Board Narrative Review
por: Mencucci, Rita, et al.
Publicado: (2021)

Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease
por: Steven, Philipp, et al.
Publicado: (2017)

High Molecular Weight Hyaluronan Promotes Corneal Nerve Growth in Severe Dry Eyes
por: van Setten, Gysbert-Botho, et al.
Publicado: (2020)

Efficacy and safety of dual-polymer hydroxypropyl guar- and hyaluronic acid-containing lubricant eyedrops for the management of dry-eye disease: a randomized double-masked clinical study
por: Labetoulle, Marc, et al.
Publicado: (2018)

Safety and Tolerability of an Eye Drop Based on 0.6% Povidone–Iodine Nanoemulsion in Dry Eye Patients
por: Oliverio, Giovanni William, et al.
Publicado: (2021)

Hyaluronic Acid as an Alternative to Autologous Human Serum Eye Drops: Initial Clinical Results with High-Molecular-Weight Hyaluronic Acid Eye Drops
por: Beck, Ria, et al.
Publicado: (2019)

Topical ocular 0.1% cyclosporine A cationic emulsion in dry eye disease patients with severe keratitis: experience through the French early-access program
por: Pisella, Pierre-Jean, et al.
Publicado: (2018)

Dry Eye Disease: What Is the Role of Vitamin D?
por: Rolando, Maurizio, et al.
Publicado: (2023)

MSC Transplantation Improves Lacrimal Gland Regeneration after Surgically Induced Dry Eye Disease in Mice
por: Dietrich, Jana, et al.
Publicado: (2019)

Real-World Effectiveness, Tolerability and Safety of Cyclosporine A 0.1% Cationic Emulsion in Severe Keratitis and Dry Eye Treatment
por: Geerling, Gerd, et al.
Publicado: (2022)

Performance and Safety of a Sodium Hyaluronate Tear Substitute with Polyethylene Glycol in Dry Eye Disease: A Multicenter, Investigator-Masked, Randomized, Noninferiority Trial
por: Labetoulle, Marc, et al.
Publicado: (2022)

The correct diagnosis and therapeutic management of tear dysfunction: recommendations of the P.I.C.A.S.S.O. board
por: Rolando, Maurizio, et al.
Publicado: (2017)

Safety and Efficacy of a Preservative-Free Artificial Tear Containing Carboxymethylcellulose and Hyaluronic Acid for Dry Eye Disease: A Randomized, Controlled, Multicenter 3-Month Study
por: Aragona, Pasquale, et al.
Publicado: (2020)

Commercially Available Eye Drops Containing Trehalose Protect Against Dry Conditions via Autophagy Induction
por: Hernandez, Eva, et al.
Publicado: (2021)

Defining the needs and preferences of patients with dry eye disease
por: Asbell, Penny, et al.
Publicado: (2019)

Establishing the tolerability and performance of tamarind seed polysaccharide (TSP) in treating dry eye syndrome: results of a clinical study
por: Rolando, Maurizio, et al.
Publicado: (2007)

Clinical Efficacy, Tolerability and Safety of a New Multiple-Action Eyedrop in Subjects with Moderate to Severe Dry Eye
por: Roszkowska, Anna Maria, et al.
Publicado: (2022)

Influence of short-term face mask wear on semiautomatically measured tear film parameters in dry eye patients and healthy volunteers
por: Schargus, Marc, et al.
Publicado: (2022)

Proinflammatory Markers, Chemokines, and Enkephalin in Patients Suffering from Dry Eye Disease
por: Nicolle, Pierre, et al.
Publicado: (2018)

One-Year Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease
por: Baudouin, Christophe, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_eb8fcgptqn04d77b2f5ej5m177